Guided Therapeutics, Inc.
GTHP
$0.1088
$0.00888.80%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.00K | -- | -- | 6.00K | 32.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.00K | -- | -- | 6.00K | 32.00K |
| Cost of Revenue | 3.00K | -- | -- | 2.00K | 16.00K |
| Gross Profit | -2.00K | -- | -- | 4.00K | 16.00K |
| SG&A Expenses | 392.00K | 450.00K | 433.00K | 309.00K | -324.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 535.00K | 561.00K | 655.00K | 365.00K | -222.20K |
| Operating Income | -534.00K | -561.00K | -655.00K | -359.00K | 254.20K |
| Income Before Tax | -652.00K | -654.00K | -709.00K | -402.00K | -386.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -652.00K | -654.00K | -709.00K | -402.00K | -386.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -652.00K | -654.00K | -709.00K | -402.00K | -386.00K |
| EBIT | -534.00K | -561.00K | -655.00K | -359.00K | 254.20K |
| EBITDA | -532.00K | -559.00K | -652.00K | -357.00K | 256.20K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 61.57M | 57.04M | 55.99M | 54.75M | 52.76M |
| Average Diluted Shares Outstanding | 61.57M | 57.04M | 55.99M | 54.75M | 52.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |